Cronos Group, Inc. (CRON)
3.375
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
3.375
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Debt to Equity Ratio : 0.0012 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0012 |
| March 31, 2026 | 0.0012 |
| December 31, 2025 | 0.0014 |
| September 30, 2025 | 0.0016 |
| June 30, 2025 | 0.0019 |
| March 31, 2025 | 0.0017 |
| December 31, 2024 | 0.0019 |
| September 30, 2024 | 0.0017 |
| June 30, 2024 | 0.0019 |
| March 31, 2024 | 0.0021 |
| December 31, 2023 | 0.0023 |
| September 30, 2023 | 0.0024 |
| June 30, 2023 | 0.0028 |
| March 31, 2023 | 0.0031 |
| December 31, 2022 | 0.0034 |
| September 30, 2022 | 0.0058 |
| June 30, 2022 | 0.0069 |
| March 31, 2022 | 0.007 |
| December 31, 2021 | 0.0073 |
| September 30, 2021 | 0.0071 |
| June 30, 2021 | 0.0046 |
| March 31, 2021 | 0.006 |
| December 31, 2020 | 0.0057 |
| September 30, 2020 | 0.0056 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0061 |
| March 31, 2020 | 0.0061 |
| December 31, 2019 | 0.0041 |
| September 30, 2019 | 0.0038 |
| June 30, 2019 | 0.0029 |
| March 31, 2019 | 0.0047 |
| December 31, 2018 | 0.0008 |
| September 30, 2018 | 0.0258 |
| June 30, 2018 | 0.0245 |
| March 31, 2018 | 0.0426 |
| December 31, 2017 | 0.06 |
| September 30, 2017 | 0.0872 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.079 |
| December 31, 2016 | 0.1188 |
| September 30, 2016 | 0.1309 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.1293 |
| December 31, 2015 | 0.1337 |
| September 30, 2015 | 0.181 |
| June 30, 2015 | 0.1554 |
| March 31, 2015 | 0.0124 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Lexaria Bioscience Corp. | 0.0183 |
| Target Group, Inc. (Canada) | -1.291 |
| Tilray Brands, Inc. | 0.2468 |
| InMed Pharmaceuticals, Inc. | 0.061 |
| NervGen Pharma Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.180B |
| Total Liabilities (Quarterly) | 62.42M |
| Shareholders Equity (Quarterly) | 1.069B |
| Current Ratio | 16.18 |
| Net Debt Paydown Yield | 0.01% |